Overview
Rubella virus vaccine is a live attenuated virus vaccine for active immunization against rubella (German measles) that is subcutaneously administered. It is prepared from RA 27/3 strain of live attenuated rubella virus. Rubella is a common childhood disease, caused by rubella virus (togavirus).
Background
Rubella virus vaccine is a live attenuated virus vaccine for active immunization against rubella (German measles) that is subcutaneously administered. It is prepared from RA 27/3 strain of live attenuated rubella virus. Rubella is a common childhood disease, caused by rubella virus (togavirus).
Indication
Rubella virus vaccine is used to prevent rubella in combination with other virus vaccines, such as the mumps and measles virus vaccine.
Associated Conditions
- Measles
- Mumps
- Rubella
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2018/08/08 | Phase 3 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Nutritional Specialties, Inc. | 83027-0071 | ORAL | 30 [hp_X] in 1 mL | 5/15/2025 | |
Nutritional Specialties, Inc. | 83027-0070 | ORAL | 16 [hp_X] in 1 mL | 5/15/2025 | |
The Wellness Center for Research and Education, Inc. | 50181-0042 | ORAL | 30 [hp_X] in 1 mL | 5/28/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
Authorised | 5/5/2006 |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
M-M-R II VACCINE | SIN02056P | INJECTION, POWDER, FOR SOLUTION | min 1000 CCID50/0.5 ml | 6/24/1988 | |
PRIORIX VACCINE | SIN10822P | INJECTION, POWDER, FOR SOLUTION | min 1000 TCID50 | 3/22/1999 | |
ProQuad Refrigerator Stable Formulation | SIN13563P | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 3.00 log TCID 50/ dose | 10/23/2008 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
PROQUAD VACCINE | N/A | merck sharp & dohme (asia) ltd | N/A | N/A | 10/5/2006 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
PRIORIX ALBUMIN FREE VACCINE 0.5mL powder for injection vial and diluent syringe | 97842 | Medicine | A | 11/3/2003 | |
PRIORIX-TETRA Vaccine 0.5mL powder for injection vial with diluent syringe | 107286 | Medicine | A | 11/16/2005 | |
M-M-R II powder for injection vial with diluent pre-filled syringe, single dose | 201877 | Medicine | A | 12/12/2012 | |
M-M-R II Powder for Injection Vial with Diluent Vial, single dose | 118449 | Medicine | A | 2/14/2006 | |
PROQUAD measles, mumps, rubella, varicella live virus vaccine injection vial with sterile diluent vial composite pack | 337388 | Medicine | A | 8/12/2020 | |
M-M-R II Powder for Injection Vial, single dose | 118451 | Medicine | A | 2/14/2006 | |
PROQUAD measles, mumps, rubella, varicella live virus vaccine injection vial | 126153 | Medicine | A | 2/8/2007 | |
PROQUAD measles, mumps, rubella, varicella live virus vaccine injection vial with prefilled diluent syringe | 126157 | Medicine | A | 2/8/2007 |